Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
    86.
    发明授权
    Use of anti-IL-6 antibodies having specific binding properties to treat cachexia 有权
    使用具有特异性结合特性的抗IL-6抗体治疗恶病质

    公开(公告)号:US08178101B2

    公开(公告)日:2012-05-15

    申请号:US12391717

    申请日:2009-02-24

    摘要: The present invention is directed to antibodies and fragments thereof and humanized versions thereof having binding specificity for IL-6. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the VH, VL and CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-IL-6 antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-IL-6 antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-IL-6 antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with IL-6. These antibodies may bind at least one of soluble IL-6, cell surface expressed IL-6, IL-6/IL-6R and/or prevent the association of IL-6 and IL-6R, the association of IL-6/IL-6R and gp130 and or the formation of IL-6/IL-6R/gp130 multimers and thereby inhibit a biological effect associated with any of the foregoing.

    摘要翻译: 本发明涉及对IL-6具有结合特异性的抗体及其片段和人源化形式。 本发明的另一个实施方案涉及本文所述的抗体及其结合片段,其包含本文所述的VH,VL和CDR多肽的序列,以及编码它们的多核苷酸。 本发明还涉及抗IL-6抗体及其与一个或多个功能或可检测部分缀合的结合片段的缀合物。 本发明还考虑制备所述抗IL-6抗体及其结合片段的方法。 本发明的实施方案还涉及抗IL-6抗体及其结合片段用于诊断,评估和治疗与IL-6相关的疾病和病症的用途。 这些抗体可以结合可溶性IL-6,细胞表面表达的IL-6,IL-6 / IL-6R中的至少一种和/或阻止IL-6和IL-6R的结合,IL-6 / IL -6R和gp130,或者形成IL-6 / IL-6R / gp130多聚体,从而抑制与前述任何相关的生物学作用。

    Compositions and methods for increasing bone mineralization
    89.
    发明授权
    Compositions and methods for increasing bone mineralization 有权
    增加骨矿化的组合物和方法

    公开(公告)号:US07985834B2

    公开(公告)日:2011-07-26

    申请号:US12504296

    申请日:2009-07-16

    IPC分类号: C07K11/00 C07K14/00 A61K38/04

    摘要: A novel class or family of TGF-β binding proteins is disclosed. Also disclosed are assays for selecting molecules for increasing bone mineralization and methods for utilizing such molecules. In particular, compositions and methods relating to antibodies that specifically bind to TGF-beta binding proteins are provided. These methods and compositions relate to altering bone mineral density by interfering with the interaction between a TGF-beta binding protein sclerostin and a TGF-beta superfamily member, particularly a bone morphogenic protein. Increasing bone mineral density has uses in diseases and conditions in which low bone mineral density typifies the condition, such as osteopenia, osteoporosis, and bone fractures.

    摘要翻译: 一种新型的TGF- 公开了结合蛋白。 还公开了用于选择用于增加骨矿化的分子的测定法和利用这种分子的方法。 特别地,提供了与特异性结合TGF-β结合蛋白的抗体相关的组合物和方法。 这些方法和组合物涉及通过干扰TGF-β结合蛋白质硬化蛋白和TGF-β超家族成员,特别是骨形态发生蛋白之间的相互作用来改变骨矿物质密度。 增加骨矿物质密度在低骨矿物质密度代表骨质减少症,骨质疏松症和骨折等疾病和病症中具有应用价值。

    Antibodies to IL-6 and use thereof
    90.
    发明申请
    Antibodies to IL-6 and use thereof 审中-公开
    IL-6抗体及其用途

    公开(公告)号:US20100290993A1

    公开(公告)日:2010-11-18

    申请号:US12601295

    申请日:2008-05-21

    摘要: The present invention is directed to antibodies and fragments thereof having binding specificity for IL-6. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the VH, VL and CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-IL-6 antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-IL-6 antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-IL-6 antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with IL-6. These antibodies may bind at least one of soluble IL-6, cell surface expressed IL-6, IL-6/IL-6R and/or prevent the association of IL-6 and IL-6R, the association of IL-6/IL-6R and gp130 and or the formation of IL-6/IL-6R/gp130 multimers and thereby inhibit a biological effect associated with any of the foregoing.

    摘要翻译: 本发明涉及对IL-6具有结合特异性的抗体及其片段。 本发明的另一个实施方案涉及本文所述的抗体及其结合片段,其包含本文所述的VH,VL和CDR多肽的序列,以及编码它们的多核苷酸。 本发明还涉及抗IL-6抗体及其与一个或多个功能或可检测部分缀合的结合片段的缀合物。 本发明还考虑制备所述抗IL-6抗体及其结合片段的方法。 本发明的实施方案还涉及抗IL-6抗体及其结合片段用于诊断,评估和治疗与IL-6相关的疾病和病症的用途。 这些抗体可以结合可溶性IL-6,细胞表面表达的IL-6,IL-6 / IL-6R中的至少一种和/或阻止IL-6和IL-6R的结合,IL-6 / IL -6R和gp130,或者形成IL-6 / IL-6R / gp130多聚体,从而抑制与前述任何相关的生物学作用。